SEK 274.3
(0.94%)
Year | Total Debt | Total Debt Growth |
---|---|---|
2023 | 31.78 Million SEK | -61.36% |
2022 | 82.26 Million SEK | 31.36% |
2021 | 62.62 Million SEK | -14.74% |
2020 | 73.45 Million SEK | -15.97% |
2019 | 87.41 Million SEK | 177.68% |
2018 | 31.48 Million SEK | 12.1% |
2017 | 28.08 Million SEK | 33.83% |
2016 | 20.98 Million SEK | -6.57% |
2015 | 22.45 Million SEK | 150.42% |
2014 | 8.96 Million SEK | 47.23% |
2013 | 6.09 Million SEK | -77.02% |
2012 | 26.5 Million SEK | 53.06% |
2011 | 17.31 Million SEK | 0.0% |
2010 | - SEK | 0.0% |
2009 | - SEK | -100.0% |
2008 | 95 Thousand SEK | -15.18% |
2007 | 112 Thousand SEK | 0.0% |
2006 | - SEK | 0.0% |
2005 | - SEK | -100.0% |
2004 | 13.87 Million SEK | -65.28% |
2003 | 39.95 Million SEK | 39.94% |
2002 | 28.55 Million SEK | 25.65% |
2001 | 22.72 Million SEK | 0.0% |
Year | Total Debt | Total Debt Growth |
---|---|---|
2024 Q1 | 45.88 Million SEK | 44.34% |
2023 Q1 | 78 Million SEK | -5.18% |
2023 Q4 | 31.78 Million SEK | 30.75% |
2023 Q3 | 24.31 Million SEK | -15.25% |
2023 Q2 | 28.68 Million SEK | -63.22% |
2023 FY | 31.78 Million SEK | -61.36% |
2022 Q3 | 80.42 Million SEK | 49.92% |
2022 FY | 82.26 Million SEK | 31.36% |
2022 Q2 | 53.64 Million SEK | -6.96% |
2022 Q1 | 57.66 Million SEK | -7.92% |
2022 Q4 | 82.26 Million SEK | 2.28% |
2021 Q1 | 68.79 Million SEK | -6.34% |
2021 Q2 | 66.89 Million SEK | -2.77% |
2021 Q3 | 66.36 Million SEK | -0.8% |
2021 Q4 | 62.62 Million SEK | -5.63% |
2021 FY | 62.62 Million SEK | -14.74% |
2020 FY | 73.45 Million SEK | -15.97% |
2020 Q1 | 53.6 Million SEK | -38.68% |
2020 Q3 | 73.86 Million SEK | 26.09% |
2020 Q2 | 58.58 Million SEK | 9.3% |
2020 Q4 | 73.45 Million SEK | -0.56% |
2019 Q3 | 579.64 Million SEK | 628.39% |
2019 Q2 | 79.58 Million SEK | -6.06% |
2019 Q1 | 84.71 Million SEK | 169.11% |
2019 FY | 87.41 Million SEK | 177.68% |
2019 Q4 | 87.41 Million SEK | -84.92% |
2018 Q1 | 28.52 Million SEK | 1.59% |
2018 Q3 | 6.45 Million SEK | -78.05% |
2018 Q4 | 31.48 Million SEK | 387.99% |
2018 FY | 31.48 Million SEK | 12.1% |
2018 Q2 | 29.38 Million SEK | 3.01% |
2017 Q1 | 56.61 Million SEK | 169.79% |
2017 FY | 28.08 Million SEK | 33.83% |
2017 Q3 | 28.52 Million SEK | -49.61% |
2017 Q2 | 56.61 Million SEK | 0.0% |
2017 Q4 | 28.08 Million SEK | -1.56% |
2016 Q1 | 50.09 Million SEK | 123.06% |
2016 FY | 20.98 Million SEK | -6.57% |
2016 Q3 | 56.61 Million SEK | 13.01% |
2016 Q2 | 50.09 Million SEK | 0.0% |
2016 Q4 | 20.98 Million SEK | -62.93% |
2015 Q3 | 52.56 Million SEK | 38.45% |
2015 Q2 | 37.96 Million SEK | 0.0% |
2015 Q1 | 37.96 Million SEK | 323.37% |
2015 Q4 | 22.45 Million SEK | -57.28% |
2015 FY | 22.45 Million SEK | 150.42% |
2014 Q4 | 8.96 Million SEK | -80.9% |
2014 Q3 | 46.94 Million SEK | 65.12% |
2014 Q2 | 28.42 Million SEK | 0.0% |
2014 Q1 | 28.42 Million SEK | 366.74% |
2014 FY | 8.96 Million SEK | 47.23% |
2013 Q4 | 6.09 Million SEK | -83.71% |
2013 Q1 | 20.41 Million SEK | -22.98% |
2013 Q2 | 27.17 Million SEK | 33.12% |
2013 Q3 | 37.39 Million SEK | 37.63% |
2013 FY | 6.09 Million SEK | -77.02% |
2012 Q1 | - SEK | -100.0% |
2012 Q3 | - SEK | -100.0% |
2012 Q4 | 26.5 Million SEK | 0.0% |
2012 FY | 26.5 Million SEK | 53.06% |
2012 Q2 | 20.45 Million SEK | 0.0% |
2011 Q2 | - SEK | -100.0% |
2011 Q1 | 6.09 Million SEK | 0.0% |
2011 FY | 17.31 Million SEK | 0.0% |
2011 Q4 | 17.31 Million SEK | 0.32% |
2011 Q3 | 17.26 Million SEK | 0.0% |
2010 Q4 | - SEK | 0.0% |
2010 FY | - SEK | 0.0% |
2010 Q3 | - SEK | 0.0% |
2010 Q1 | - SEK | 0.0% |
2010 Q2 | - SEK | 0.0% |
2009 Q4 | - SEK | 0.0% |
2009 FY | - SEK | -100.0% |
2008 FY | 95 Thousand SEK | -15.18% |
2007 FY | 112 Thousand SEK | 0.0% |
2006 FY | - SEK | 0.0% |
2005 FY | - SEK | -100.0% |
2004 FY | 13.87 Million SEK | -65.28% |
2003 FY | 39.95 Million SEK | 39.94% |
2002 FY | 28.55 Million SEK | 25.65% |
2001 FY | 22.72 Million SEK | 0.0% |
Name | Total Debt | Total Debt Difference |
---|---|---|
Acarix AB (publ) | - SEK | -Infinity% |
ADDvise Group AB (publ) | 1.61 Billion SEK | 98.03% |
ADDvise Group AB (publ) | 1.61 Billion SEK | 98.03% |
Arcoma AB | 3.87 Million SEK | -720.759% |
Bactiguard Holding AB (publ) | 233.09 Million SEK | 86.363% |
BICO Group AB (publ) | 1.85 Billion SEK | 98.285% |
Boule Diagnostics AB (publ) | 166.1 Million SEK | 80.862% |
CellaVision AB (publ) | 64.7 Million SEK | 50.871% |
Clinical Laserthermia Systems AB (publ) | 454 Thousand SEK | -6901.762% |
Chordate Medical Holding AB (publ) | - SEK | -Infinity% |
C-Rad AB (publ) | 1.8 Million SEK | -1666.0% |
Duearity AB (publ) | 10.58 Million SEK | -200.397% |
Dignitana AB (publ) | 19.1 Million SEK | -66.394% |
Episurf Medical AB (publ) | 5.2 Million SEK | -511.308% |
Getinge AB (publ) | 8.07 Billion SEK | 99.606% |
Scandinavian Real Heart AB (Publ) | 8.24 Million SEK | -285.327% |
Iconovo AB (publ) | 7.72 Million SEK | -311.5% |
Integrum AB (publ) | 6.42 Million SEK | -394.818% |
Luxbright AB (publ) | 206.02 Thousand SEK | -15329.27% |
Mentice AB (publ) | 9.55 Million SEK | -232.615% |
OssDsign AB (publ) | 3.15 Million SEK | -909.143% |
Paxman AB (publ) | 13.57 Million SEK | -134.252% |
Promimic AB (publ) | - SEK | -Infinity% |
Qlife Holding AB (publ) | 20.73 Million SEK | -53.336% |
SciBase Holding AB (publ) | 6.79 Million SEK | -367.677% |
ScandiDos AB (publ) | - SEK | -Infinity% |
Sedana Medical AB (publ) | 4.3 Million SEK | -638.226% |
Senzime AB (publ) | 11.46 Million SEK | -177.189% |
SpectraCure AB (publ) | 6.71 Million SEK | -373.247% |
Stille AB | 62.94 Million SEK | 49.496% |
Vitrolife AB (publ) | 2.08 Billion SEK | 98.478% |
Xvivo Perfusion AB (publ) | 31.43 Million SEK | -1.117% |